Price
263.8
-6.19%52W Range
Market Cap
₹151.69 Cr
Traded: ₹0.02 Cr (0.01%) 0.0x
Free Float: ₹28.03 Cr (0.06% of FF traded)
Volume · 60D trend
581 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +22.0% | +21.0% | +22.0% | -- | -- | Stable |
| Sales | +12.0% | +10.0% | +13.0% | -- | +11.0% | Stable |
| Profit | +23.0% | +13.0% | +36.0% | -- | +15.0% | Stable |
| Return | -- | +86.0% | +3.0% | -17.0% | -- | Decelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 113 | 147 | 125 | 112 | 117 | 128 | 112 | 89 | 93 | 90 | 86 | 69 | 93 | 90 |
| Expenses | 108 | 143 | 122 | 109 | 115 | 124 | 107 | 85 | 90 | 90 | 82 | 67 | 91 | 89 |
| Operating Profit | 6 | 4 | 3 | 3 | 2 | 4 | 5 | 4 | 3 | -1 | 4 | 2 | 3 | 1 |
| OPM % | 5.1% | 2.8% | 2.6% | 2.3% | 1.8% | 3.0% | 4.3% | 4.8% | 3.2% | -0.8% | 4.5% | 2.3% | 2.8% | 0.9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | 3 | 3 | 2 | 1 | 3 | 4 | 4 | 2 | -1 | 3 | 1 | 2 | 0 |
| Tax % | 26.6% | 28.0% | 29.7% | -5.3% | 49.0% | 22.2% | 29.1% | 24.6% | 24.6% | -64.8% | 45.1% | 2.5% | 27.4% | 116.7% |
| Net Profit | 4 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | -0 | 2 | 1 | 1 | -0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 6.5 | 4.3 | 3.1 | 3.5 | 1.3 | 4.3 | 4.9 | 4.7 | 3.0 | -0.8 | 2.7 | 1.4 | 2.2 | -0.0 |
| Sales Growth (YoY) | -3.3% | 14.9% | 11.7% | 25.5% | 26.0% | 42.8% | 30.4% | 29.6% | -0.2% | -0.5% | -9.7% | -9.4% | 10.5% | -- |
| Sales Growth (QoQ) | -- | 17.5% | 11.9% | -4.8% | -8.3% | 14.3% | 25.7% | -4.4% | 3.9% | 4.4% | 24.9% | -26.4% | 3.6% | -- |
| OP Growth (YoY) | 168.7% | 8.7% | -32.8% | -40.7% | -27.2% | 605.3% | 26.2% | 169.4% | 13.1% | -190.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | 39.6% | 27.2% | 29.1% | 17.3% | -43.5% | -21.4% | 13.9% | 43.9% | 492.0% | -119.6% | 143.3% | -39.6% | 213.3% | -- |
| Profit Growth (YoY) | 400.0% | -1.0% | -36.0% | -26.0% | -56.0% | 651.0% | 81.0% | 245.0% | 37.0% | -2150.0% | 51.0% | 70.0% | -6.0% | -100.6% |
| EPS Growth (YoY) | -- | -0.7% | -35.7% | -25.6% | -56.5% | 652.6% | 80.8% | 244.1% | 36.5% | -2500.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 35.9% | -9.5% | 167.7% | -69.8% | -12.0% | 4.7% | 56.5% | 483.3% | -128.8% | 99.3% | -37.9% | 7400.0% | -- |
| OP Margin | -- | 2.8% | 2.6% | 2.3% | 1.8% | 3.0% | 4.3% | 4.8% | 3.2% | -0.8% | 4.5% | 2.3% | 2.8% | 0.9% |
| Net Margin | -- | 1.7% | 1.4% | 1.8% | 0.6% | 1.9% | 2.5% | 3.0% | 1.9% | -0.5% | 1.8% | 1.1% | 1.4% | -0.0% |
| Material Cost % | 93.0% | 95.0% | 95.0% | 95.0% | 96.0% | 95.0% | 94.0% | 93.0% | 94.0% | 95.0% | 93.0% | 95.0% | 95.0% | 96.0% |
| Employee Cost % | 1.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| P/S | 0.31 | 0.25 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 15.13 | 18.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.61 | 3.02 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50News Publication- Financial Results for Quarter ended 30th June 2026
With reference to the Captioned Subject, we hereby inform you that the meeting of the Board of Directors of the Company was held on Friday, August 14, 2026, at the Registered Office of ....
Un Audited Financial Result for First Quarter Ended on June 30, 2026.
Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The UnAudited Financial ....
Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018
Clarification on Price Movement of Shares
The Exchange has sought clarification from Ambar Protein Industries Ltd on July 3, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
Newspaper Publication- Public notice Regarding SEBI Special Window for Transfer and Dematerialisation of Physical Securities
Outcome of Board Meeting
Audited Financial Result for Quarter and Financial Year Ended on March, 31 2026
Annual Secretarial Compliance - Reg 24 (A)
Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. The Audited Financial ....
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Chunilal Khetani
Newspaper Publication- Public Notice Regarding SEBI Special Window For Transfer and Demat of Physical Securities.
Newspaper Publication
Unaudited Financial Result for Quarter and Nine months ended on December 2025
Outcome of the Board meeting held on February 2, 2026 to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025
Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Unaudited Financial ....
Compliance Certificate under Reg. 74 (5) of SEBI (DP) regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
Closure of Trading wINDOW
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
OUTCOME OF BOARD MEETING
Financial Result for Quarter and half year ended 30th September, 2025
Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 ,inter alia, to consider and approve The UnAudited Financial ....
Certificate under Reg. 74 (5)
Submission of voting result along with Scrutinizer Report
Closure of Trading window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Minouli Pradeepbhai Khetani
As per Regulation 36 (1)(b) of the SEBI (LODR) Regulation the Company is required to send a letter providing the web-link and exect path where the complete Annual Report is available to ....
Newspaper cliping regarding 32nd Annual General Meeting of the Company
Annual Report 2024-2025
NEWSPAPER PUBLICATION
Annual Reports
11